hoe 33342 and ER-Negative PR-Negative HER2-Negative Breast Cancer

hoe 33342 has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berindan-Neagoe, I; Braicu, C; Irimie, A; Pileczki, V	1

Other Studies

1 other study(ies) available for hoe 33342 and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
p53siRNA therapy reduces cell proliferation, migration and induces apoptosis in triple negative breast cancer cells. Molecular and cellular biochemistry, 2013, Volume: 381, Issue:1-2 Topics: Apoptosis; Benzimidazoles; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Female; Flow Cytometry; Gene Regulatory Networks; Genetic Association Studies; Humans; Immunoblotting; Microscopy, Fluorescence; RNA, Small Interfering; Staining and Labeling; Triple Negative Breast Neoplasms; Tumor Suppressor Protein p53	2013

Article

Year

p53siRNA therapy reduces cell proliferation, migration and induces apoptosis in triple negative breast cancer cells.

Molecular and cellular biochemistry, 2013, Volume: 381, Issue:1-2

Topics: Apoptosis; Benzimidazoles; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Female; Flow Cytometry; Gene Regulatory Networks; Genetic Association Studies; Humans; Immunoblotting; Microscopy, Fluorescence; RNA, Small Interfering; Staining and Labeling; Triple Negative Breast Neoplasms; Tumor Suppressor Protein p53

2013